Prediction of recurrent and residual cervical dysplasia by human papillomavirus detection among patients with abnormal cytology

Liesbeth J M Bollen, Steven P. Tjong-A-Hung, Jacobus Van Der Velden, Ben Willem Mol, Fiebo W J Ten Kate, Jan Ter Schegget, Otto P. Bleker

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

To determine the discriminative capacity of human papillomavirus (HPV) DNA testing for recurrent and residual cervical dysplasia, 43 patients with abnormal cytology after treatment for cervical dysplasia were tested for the presence of HPV DNA by PCR. An endocervical curettage was performed in all patients for histological examination. Sixteen of the 43 patients showed moderate or severe dysplasia. The HPV test was positive in all 16 patients with recurrent or residual dysplasia and negative in 12 of the 27 patients without dysplasia. The sensitivity and specificity of the HPV test were 100 and 44%, respectively. The likelihood ratio of a positive HPV test was 1.8, whereas a negative HPV test had a likelihood ratio of 0.12. Testing for the presence of HPV has the potential to select patients without recurrent or residual cervical dysplasia who have an abnormal cytological smear. This may have clinical implications, since unnecessary diagnostic conizations may be avoided in patients with abnormal cytology after treatment for cervical dysplasia and a negative HPV test.

LanguageEnglish
Pages199-201
Number of pages3
JournalGynecologic Oncology
Volume72
Issue number2
DOIs
Publication statusPublished - 1 Jan 1999

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynaecology

Cite this

Bollen, L. J. M., Tjong-A-Hung, S. P., Van Der Velden, J., Mol, B. W., Ten Kate, F. W. J., Ter Schegget, J., & Bleker, O. P. (1999). Prediction of recurrent and residual cervical dysplasia by human papillomavirus detection among patients with abnormal cytology. Gynecologic Oncology, 72(2), 199-201. https://doi.org/10.1006/gyno.1998.5250
Bollen, Liesbeth J M ; Tjong-A-Hung, Steven P. ; Van Der Velden, Jacobus ; Mol, Ben Willem ; Ten Kate, Fiebo W J ; Ter Schegget, Jan ; Bleker, Otto P. / Prediction of recurrent and residual cervical dysplasia by human papillomavirus detection among patients with abnormal cytology. In: Gynecologic Oncology. 1999 ; Vol. 72, No. 2. pp. 199-201.
@article{d78d36d11c9f4faeafb34ca41649e285,
title = "Prediction of recurrent and residual cervical dysplasia by human papillomavirus detection among patients with abnormal cytology",
abstract = "To determine the discriminative capacity of human papillomavirus (HPV) DNA testing for recurrent and residual cervical dysplasia, 43 patients with abnormal cytology after treatment for cervical dysplasia were tested for the presence of HPV DNA by PCR. An endocervical curettage was performed in all patients for histological examination. Sixteen of the 43 patients showed moderate or severe dysplasia. The HPV test was positive in all 16 patients with recurrent or residual dysplasia and negative in 12 of the 27 patients without dysplasia. The sensitivity and specificity of the HPV test were 100 and 44{\%}, respectively. The likelihood ratio of a positive HPV test was 1.8, whereas a negative HPV test had a likelihood ratio of 0.12. Testing for the presence of HPV has the potential to select patients without recurrent or residual cervical dysplasia who have an abnormal cytological smear. This may have clinical implications, since unnecessary diagnostic conizations may be avoided in patients with abnormal cytology after treatment for cervical dysplasia and a negative HPV test.",
author = "Bollen, {Liesbeth J M} and Tjong-A-Hung, {Steven P.} and {Van Der Velden}, Jacobus and Mol, {Ben Willem} and {Ten Kate}, {Fiebo W J} and {Ter Schegget}, Jan and Bleker, {Otto P.}",
year = "1999",
month = "1",
day = "1",
doi = "10.1006/gyno.1998.5250",
language = "English",
volume = "72",
pages = "199--201",
journal = "Gynecologic oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "2",

}

Bollen, LJM, Tjong-A-Hung, SP, Van Der Velden, J, Mol, BW, Ten Kate, FWJ, Ter Schegget, J & Bleker, OP 1999, 'Prediction of recurrent and residual cervical dysplasia by human papillomavirus detection among patients with abnormal cytology', Gynecologic Oncology, vol. 72, no. 2, pp. 199-201. https://doi.org/10.1006/gyno.1998.5250

Prediction of recurrent and residual cervical dysplasia by human papillomavirus detection among patients with abnormal cytology. / Bollen, Liesbeth J M; Tjong-A-Hung, Steven P.; Van Der Velden, Jacobus; Mol, Ben Willem; Ten Kate, Fiebo W J; Ter Schegget, Jan; Bleker, Otto P.

In: Gynecologic Oncology, Vol. 72, No. 2, 01.01.1999, p. 199-201.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Prediction of recurrent and residual cervical dysplasia by human papillomavirus detection among patients with abnormal cytology

AU - Bollen, Liesbeth J M

AU - Tjong-A-Hung, Steven P.

AU - Van Der Velden, Jacobus

AU - Mol, Ben Willem

AU - Ten Kate, Fiebo W J

AU - Ter Schegget, Jan

AU - Bleker, Otto P.

PY - 1999/1/1

Y1 - 1999/1/1

N2 - To determine the discriminative capacity of human papillomavirus (HPV) DNA testing for recurrent and residual cervical dysplasia, 43 patients with abnormal cytology after treatment for cervical dysplasia were tested for the presence of HPV DNA by PCR. An endocervical curettage was performed in all patients for histological examination. Sixteen of the 43 patients showed moderate or severe dysplasia. The HPV test was positive in all 16 patients with recurrent or residual dysplasia and negative in 12 of the 27 patients without dysplasia. The sensitivity and specificity of the HPV test were 100 and 44%, respectively. The likelihood ratio of a positive HPV test was 1.8, whereas a negative HPV test had a likelihood ratio of 0.12. Testing for the presence of HPV has the potential to select patients without recurrent or residual cervical dysplasia who have an abnormal cytological smear. This may have clinical implications, since unnecessary diagnostic conizations may be avoided in patients with abnormal cytology after treatment for cervical dysplasia and a negative HPV test.

AB - To determine the discriminative capacity of human papillomavirus (HPV) DNA testing for recurrent and residual cervical dysplasia, 43 patients with abnormal cytology after treatment for cervical dysplasia were tested for the presence of HPV DNA by PCR. An endocervical curettage was performed in all patients for histological examination. Sixteen of the 43 patients showed moderate or severe dysplasia. The HPV test was positive in all 16 patients with recurrent or residual dysplasia and negative in 12 of the 27 patients without dysplasia. The sensitivity and specificity of the HPV test were 100 and 44%, respectively. The likelihood ratio of a positive HPV test was 1.8, whereas a negative HPV test had a likelihood ratio of 0.12. Testing for the presence of HPV has the potential to select patients without recurrent or residual cervical dysplasia who have an abnormal cytological smear. This may have clinical implications, since unnecessary diagnostic conizations may be avoided in patients with abnormal cytology after treatment for cervical dysplasia and a negative HPV test.

UR - http://www.scopus.com/inward/record.url?scp=0032943238&partnerID=8YFLogxK

U2 - 10.1006/gyno.1998.5250

DO - 10.1006/gyno.1998.5250

M3 - Article

VL - 72

SP - 199

EP - 201

JO - Gynecologic oncology

T2 - Gynecologic oncology

JF - Gynecologic oncology

SN - 0090-8258

IS - 2

ER -